Notice to Voluntarily Withdraw a Class of Securities from Listing and Registration on a National Exchange — Form 25 Filing Table of Contents
Document/ExhibitDescriptionPagesSize 1: 25 Notice to Voluntarily Withdraw a Class of HTML 15K Securities from Listing and Registration on a National Exchange
(Address,
including zip code, and telephone number, including area code, of Issuer’s
principal executive offices)
Common
Stock, par value $0.005 per share
(Description
of class of securities)
Please
place an X in the box to designate the rule provision relied upon to strike the
class of securities from listing and registration:
¨
17
CFR 240.12d2-2(a)(1)
¨
17
CFR 240.12d2-2(a)(2)
¨
17
CFR 240.12d2-2(a)(3)
¨
17
CFR 240.12d2-2(a)(4)
¨
Pursuant
to 17 CFR 240.12d2-2(b), the Exchange has complied with its
rules to strike the class of securities from listing and/or withdraw
registration on the Exchange. 1
x
Pursuant
to 17 CFR 240.12d2-2(c), the Issuer has complied with the rules
of the Exchange and the requirements of 17 CFR 240.12d2-2(c)
governing the voluntary withdrawal of the class of securities from listing
and registration on the Exchange.
Pursuant
to the requirements of the Securities Exchange Act of 1934, Cleveland BioLabs,
Inc. certifies that it has reasonable grounds to believe that it meets all of
the requirements for filing the Form 25 and has caused this notification to be
signed on its behalf by the undersigned duly authorized person.
The
Nasdaq Stock Market, Inc. previously acquired the Boston Stock Exchange (the
“BSE”). Cleveland BioLabs, Inc. was listed on the BSE until September 2007.
Currently, our Common Stock is traded on the Nasdaq Capital Market.
1
Form
25 and attached Notice will be considered compliance with the provisions
of 17 CFR 240.19d-1 as applicable. See General
Instructions.
SEC 1654 (03-06)
Persons
who respond to the collection of information contained in this form are
not required to respond unless the form displays a currently valid OMB
control number.